Melatonin Treatment and Inflammation, Oxidative Stress and Autonomic Function in Connection With Surgery

NCT00311259 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2006-04-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether treatment with melatonin can reduce cell damage and inflammation in connection with laparoscopic gall bladder surgery.

Conditions

  • Oxidative Stress
  • Inflammatory Stress
  • Myocardial Ischaemia

Interventions

DRUG

Melatonin (drug)

DRUG

Laktose

Sponsors & Collaborators

  • University Hospital, Gentofte, Copenhagen

    lead OTHER

Principal Investigators

  • Bülent Kücükakin · Department of Surgical Gastroenterology, University Hospital of Copenhagen in Gentofte

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Completion
2006-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00311259 on ClinicalTrials.gov